The significance and novelty of this study lie in the identification of an effective Na+/K+ ATPase inhibitor, P.A, which can significantly inhibit the growth of NSCLC cells via Ca2+-induced DR4 up-regulation at the nanomolar level. This evidence concerns the gene TNFRSF10A and non-small cell lung carcinoma.